Amplification of the c-myc proto-oncogene in cervical carcinoma
β Scribed by Dr. Vicki V. Baker; Kenneth D. Hatch; Hugh M. Shingleton
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- English
- Weight
- 357 KB
- Volume
- 39
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
β¦ Synopsis
Amplification without structural rearrangements of the c-myc proto-oncogene was found in 14 of 44 primary cervical neoplasms. There was no apparent correlation with stage of disease or degree of cellular differentiation. The prognostic significance of c-myc amplification cannot be determined from this study.
π SIMILAR VOLUMES
## Abstract The cβ__erb__ Bβ2/__neu__ gene encodes a cellβsurface glycoprotein with extensive homology to, but distinct from, the epidermal growthβfactor receptor. In this study, we compared the cβ__erb__ Bβ2/__neu__ gene amplification and expression of tissue specimens obtained from the bladders o
To understand the mechanisms underlying increased expression of Myc protein in human urinary bladder cancer, expression of c-myc mRNA and the copy number of the c-myc gene were determined. Expression of mRNA was measured by quantitative RT-PCR in 40 urothelial carcinomas and in 18 histologically nor
mal and malignant epithelial cells and several other cell The c-met proto-oncogene encodes the tyrosine kinase types, including endothelial cells and melanocytes. 4,5 receptor for hepatocyte growth factor (HGF), a potent It has been reported that the expression of c-Met is enmitogen and motogen for
The c-met proto-oncogene encodes the tyrosine kinase receptor for hepatocyte growth factor (HGF), a potent mitogen and motogen for epithelial cells. Because of its profound effects on cell growth and motility, HGF may be important in the development of cancer metastases in hepatocellular carcinoma (
Expression of oncogenes in gastric cancer tissue was evaluated with immunohistochemical staining methods using monoclonal antibodies to products of the oncogenes. Rates of expression in gastric cancer tissue were 50% for c-myc, 72% for c-erb B,, and 56% for c-Ha-rus oncogenes. Expression of these on